Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter studyFumihiko Urabe, Takahiro Kimura, Taro Igarashi et al.|Japanese Journal of Clinical Oncology|2024Cited by 22
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinomaWataru Fukuokaya, Shin Egawa, Takahiro Kimura et al.|Cancer Immunology Immunotherapy|2021Cited by 11
Clear identification of the rare solitary external iliac lymph node metastasis of testicular cancer by using indocyanine green fluorescence guidanceYuki Enei, Shin Egawa, Fumihiko Urabe et al.|IJU Case Reports|2021Cited by 7
Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumabWataru Fukuokaya, Shin Egawa, Takahiro Kimura et al.|British Journal of Urology|2020Cited by 6
Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial CarcinomaWataru Fukuokaya, Shin Egawa, Takahiro Kimura et al.|Targeted Oncology|2021Cited by 6